RG7112 | RG7112 : Antagonist of MDM2
RATINGS:
Cellular Use: (2 reviews)

In Model Organisms: (2 reviews)
Selectivity
Control Compounds

Probe Summary

More...

Targets Biochemical/Biophysical Potency Cellular Potency
MDM2
  • IC50:18 nM
  • IC50:400 nM
Up to 1 uM

Selectivity

Potency
Cellular
In Vitro

MDM2

Mode of Action: Antagonist

Structure-Activity-Relationship data available? No

DOI Reference: 10.1021/ml4000657

In Vivo Validations

Mouse
Dose: 50 mg/kg
Route of delivery: Oral
Plasma half life: 8.8 h
Organ of interest (O): Subcutaneous xenografts (GBM and osteosarcoma), Brain engraftment (GBM)
Target engagement assay: In subcutaneous GBM xenografts, RG7112 increase expression of MDM2, p53 and p21.

DOI Reference: 10.1021/ml4000657

Orthogonal Probes def

AM-6761
NAVTEMADLIN
MD-4251

Chemical Information

Molecular Formula C38H48Cl2N4O4S
SMILEs CCOc1cc(C(C)(C)C)ccc1C1=N[C@@](C)(c2ccc(Cl)cc2)[C@@](C)(c2ccc(Cl)cc2)N1C(=O)N1CCN(CCCS(C)(=O)=O)CC1
InChI InChI=1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3/t37-,38+/m0/s1
Molecular weight 726.28 Da
AlogP 7.754900000000013
HBond acceptors 8
HBond donors --
Atoms 97

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the Portal.

Expert Reviews


(on 7 Jun 2017)
Cellular Use Rating
In Model Organisms
(The reviewer did not leave any public comments)
(on 28 Jun 2017)
Cellular Use Rating
In Model Organisms
Public notes can be found at http://www.citeulike.org/user/cdsouthan/article/14369611. Note it will also go live in the Guide to Pharmacology by August 2017 (Ligand 9699). Configuration of the...
If you would like to explore AI-generated evaluations, you may wish to visit the page for this compound on our collaborator website
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria